Levofloxacin (Compound)

Synonyms:LEVOFLOXACIN, 100986-85-4, Levaquin, Quixin, (-)-Ofloxacin, Cravit, Iquix, Ofloxacin S-(-)-form, Tavanic, Levofloxacine, (S)-Ofloxacin, L-Ofloxacin, Levofloxacino, Levofloxacinum, Oftaquix, Floxacin, Levofloxacin Anhydrous, DR-3355, Nofaxin, Volequin, FLUOROQUINOLONE, Levofloxacin (Levaquin), Levofloxacin hydrate, MP-376, Levofloxacin (INN), RWJ-25213, Levaquin (TN), Elequine, (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, NSC-758709, RIX4E89Y14, (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-, CHEBI:63598, Quinsair, MFCD00865049, MMV687798, Ofloxacin, (s)-, LEVOFLOXACIN [INN], (S)-(-)-Ofloxacin, (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid, (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, LFX, Levofloxacine [INN-French], Levofloxacinum [INN-Latin], Levofloxacino [INN-Spanish], DR3355, HR 355, Aeroquin, Unibiotic, Venaxan, Levofloxacin [USAN:INN:JAN], Loxof, Levofloxacin (as hemihydrate), RWJ 25213-097, (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid, (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, SMR000466387, Cravit (TN), S-(-)-Ofloxacin, CCRIS 4074, LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, UNII-RIX4E89Y14, Levofiexacin, Ofloxcacin, S-ofloxacin, HSDB 8028, Cravit IV, Levofloxacin,(S), Anhydrous Ofloxacin, DR-3355: L-isomer of ofloxacin, (3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, HR-355, MP 376, Spectrum_001719, CPD000466387, Spectrum2_001676, Spectrum3_000995, Spectrum4_001123, Spectrum5_001438, SCHEMBL15397, BSPBio_002689, KBioGR_001605, KBioSS_002199, (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid, MLS000759524, MLS001165709, MLS001423977, LEVOFLOXACIN [WHO-DD], SPECTRUM1504260, SPBio_001891, DTXSID0041060, GTPL10911, KBio2_002199, KBio2_004767, KBio2_007335, KBio3_001909, Ofloxacin s-(-)-form hemihydrate, HMS1922J07, HMS2051G04, HMS2090O10, HMS2093E18, HMS2232G06, Pharmakon1600-01504260, EX-A1488, HY-B0330, Levofloxacin, >=98.0% (HPLC), BDBM50366826, CCG-39093, DE-108, NSC755604, NSC758709, s1940, OFLOXACIN S-(-)-FORM [MI], AKOS008901361, AKOS015895104, AC-7593, DB01137, NC00094, NSC 758709, NSC-755604, NCGC00178529-01, NCGC00178529-02, NCGC00178529-03, NCGC00178529-06, 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-, AS-31796, Levofloxacin, analytical reference material, SBI-0206768.P001, L0193, C07660, D08120, AB00171657-12, AB00171657-13, AB00171657_14, AB00171657_15, Q424193, SR-05000001999, Levofloxacin, Antibiotic for Culture Media Use Only, Q-201295, SR-05000001999-1, BRD-K09471561-001-06-7, tert-butyl?2-(hydroxymethyl)pyrrolidine-1-carboxylate, Z1590790198, ()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (2S)-7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate, (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
Pubchem:PUBCHEM:149096
Id:47c97aee-039d-5739-ac31-1ff19f454418
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Levofloxacin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Levofloxacin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Levofloxacin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.